Methodology and Apparatus for the Detection of Biological Substances

• US 20070159325A1
• Filed: 07/10/2006
• Published: 07/12/2007
• Est. Priority Date: 11/16/2004
• Status: Abandoned Application

• Current Assignee: BioWarn LLC (KKR & Co., Inc.)
• Original Assignee: Biowam LLC
• Inventors: Oleynik, Vladislav
• Application Number:
  US11/456,479
• Publication Number:
  US 20070159325A1
• Time in Patent Office: Days
• US Class Current: 340/539.260
• CPC Class Codes: G01N 27/4145 specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
• CPC Class Codes: G01N 33/5438 Electrodes

Abstract

A methodology and an apparatus for the detection of biological substances employing the integration of multiple functions and units designed into and implemented in the form of an individual silicon chip, described as a sensor unit. The deployment of a set of sensor units as a group results in a distributed detecting, discriminating, and alerting network. Distribution of the sensor units facilitates the on-the-spot detection of different biological substances such as viruses, bacteria, spores, allergens, and other toxins that can be suspended in multiple media (air, liquid, blood, etc.). Besides detection/sensing, the individual sensor units perform: data acquisition, data development, data storage, statistical analysis, and data transmission.

Claims

1. A system for determining the presence of a biological target, comprising:

a. a sensor array comprising;

i. at least one sensor element, each sensor element further comprising;

1. a plurality of ligands of at least one ligand type applied to a coating on the sensor element;

2. an electrostatic output signal generated by the sensor element from an interaction when one of the plurality of ligands of the at least one ligand type binds to at least one biological target type;

3. an electrostatic sensing surface, positioned in proximity to the at least one ligand for detecting the electrostatic output signal; and

a measurement means for measuring the detected electrostatic output signal;

b. a controller for controlling a sequencing of the selection of sensor elements within the array to sequentially select a column of the sensor array, to sequentially select each of the rows of the array and then to sequentially select and input a sample of the electrostatic output signal of each sensor element;

c. means for converting the sample of the electrostatic output signal of the sensor element from an analog signal to a digital equivalent signal by a digital-to-analog converter, the digital equivalent sample signal being combined with other digital equivalent sample signals from a same sensor element and stored in the controller to form a digital signature signal;

d. means for transmitting the digital signature signal to a digital signal processor which compares the digital signature signal with a library of pre-stored signature signals representing known biological targets; and

e. means for generating a notification alert when the digital signature signal matches a pre-stored signal type in the library of pre-stored signature signals that represents a signature generated when the at least one ligand type binds with the at least one biological target.

2. A system for determining the presence of a biological target in accordance with claim 1 wherein:

a. the binding of the at least one ligand with the at least one biological target;

b. the detecting and measuring of the electrostatic output signal;

c. the controlling of the sequencing of the selection of sensor elements within the array and selecting of the electrostatic output signal of each sensor element;

d. the converting of the electrostatic output signal to the digital equivalent signal;

e. the transmitting and the comparing of the digital equivalent signal to the library of pre-stored signature signals representing known biological targets; and

f. said binding, detecting, measuring, controlling, converting, transmitting and comparing occurs in real-time.

3. A system for determining the presence of a biological target in accordance with claim 1 wherein the at least one ligand type is an antibody for a protein hemagglutinin subtype H5.

4. A system for determining the presence of a biological target in accordance with claim 1 wherein the at least one ligand type is an antibody for a protein neuraminidase subtype N1.

5. A system for determining the presence of a biological target in accordance with claim 1 wherein the at least one ligand type is an antibody for a protein P24.

6. A system for determining the presence of a biological target in accordance with claim 1 further comprising:

a. the at least one ligand type of a first sensor element is selected from the group consisting of an antibody for a protein hemagglutinin; and

b. the at least one ligand type of a second sensor element is selected from the group consisting of an antibody for a protein neuraminidase.

7. A system for determining the presence of a biological target in accordance with claim 1 wherein each sensor element within the sensor array comprises at least one ligand type selected from the group consisting of antibodies for proteins hemagglutinin and neuraminidase.

8. A system for determining the presence of a biological target in accordance with claim 1 wherein each sensor element within the sensor array comprises at least one ligand type selected from the group consisting of antibodies for a protein P24.

9. A system for determining the presence of a biological target in accordance with claim 3 wherein the at least one biological target type are antigens of the protein hemagglutinin subtype H5 that bind with the at least one ligand type antibody for the protein hemagglutinin subtype H5.

10. A system for determining the presence of a biological target in accordance with claim 4 wherein the at least one biological target type are antigens of the protein neuraminidase subtype N1 that bind with the at least one ligand type antibody for the protein neuraminidase subtype N1.

11. A system for determining the presence of a biological target in accordance with claim 5 wherein the at least one biological target type are antigens of the protein p24 that bind with the at least one ligand type antibody for the protein p24.

12. A system for determining the presence of a biological target in accordance with claim 1 further comprising:

a. a first sensor element of the sensor array wherein the first sensor element comprises a plurality of ligands of a first ligand type that is an antibody for hemagglutinin subtype H5;

b. a second sensor element of the sensor array wherein the second sensor element comprises a plurality of ligands of a second ligand type neuraminidase subtype N1;

c. means for detecting a first electrostatic output signal when an influenza virus containing an hemagglutinin subtype H5 antigen is introduced in proximity to the first sensor element;

d. means for detecting a second electrostatic output signal when an influenza virus containing an neuraminidase subtype N1 antigen is introduced in proximity to the second sensor element;

e. means for controlling the sequencing of the selection of the first and second sensor elements to read samples of the first and second electrostatic output signals;

f. means for converting the first and second electrostatic output signal samples to first and second digital equivalent sample signals;

g. means for combining a plurality of first digital equivalent sample signals from a same sensor element to form a first digital signature signal and combining a plurality of second digital equivalent sample signals from a same sensor element to form a second digital signature signal;

h. means for transmitting the first and second digital signature signals to a digital signal processor which compares the first and second digital signature signals to the library of pre-stored signature signals containing a first pre-stored signature signal representing a binding event when the first ligand type for hemagglutinin subtype H5 binds with a hemagglutinin subtype H5 antigen and a second pre-stored signature signal representing a binding event when the second ligand type for neuraminidase subtype N1 binds with a neuraminidase subtype N1 antigen; and

i. means for generating an alert upon matching both the first digital signature signal with the first pre-stored signature signal and the second digital signature signal with the second pre-stored signature signal.

13. A system for determining the presence of a biological target in accordance with claim 1 further comprising:

a. a first sensor element of the sensor array wherein the first sensor element comprises a plurality of ligands of a first ligand type that is an antibody for hemagglutinin subtype H5;

b. a second sensor element of the sensor array wherein the second sensor element comprises a plurality of ligands of a second ligand type that is an antibody for neuraminidase subtype N1;

c. means for detecting a first electrostatic output signal when an influenza virus containing an hemagglutinin subtype antigen selected from the group consisting of H1 through H4 and H6 through H16 is introduced in proximity to the first and second sensor elements;

d. means for detecting a second electrostatic output signal when an influenza virus containing a neuraminidase subtype antigen selected from the group consisting of N2 through N9 is introduced in proximity to the first and second sensor elements;

e. means for controlling the sequencing of the selection of the first and second sensor elements to read samples of the first and second electrostatic output signals;

f. means for converting the first and second electrostatic output signal samples to first and second digital equivalent sample signals;

g. means for combining a plurality of first digital equivalent sample signals from a same sensor element to form a first digital signature signal and combining a plurality of second digital equivalent sample signals from a same sensor element to form a second digital signature signal;

h. means for transmitting the first and second digital signature signals to a digital signal processor which compares the first and second digital signature signals to a library of pre-stored signature signals containing binding events representing a binding of an antibody for hemagglutinin subtype selected from the group consisting of H1 through H4 and H6 through H16 and representing a binding of an antibody for neuraminidase subtype selected from the group consisting of N2 through N9; and

i. means for indicating that the antigen hemagglutinin subtype selected from the group consisting of H1 through H4 and H6 through H16 and the antigen neuraminidase subtype selected from the group consisting of N2 through N9 have been detected.

14. A system for determining the presence of a biological target in accordance with claim 1 further comprising:

a. a first sensor element of the sensor array wherein the first sensor element comprises a plurality of ligands of a first ligand type that is an antibody for hemagglutinin subtype H5;

b. a second sensor element of the sensor array wherein the second sensor element comprises a plurality of ligands of a second ligand type that is an antibody for neuraminidase subtype N1;

c. a third sensor element of the sensor array wherein the third sensor element comprises a plurality of ligands of a ligand type that is an antibody for hemagglutinin with a subtype selected from the group consisting of H1 through H4 and H6 through H16;

d. a fourth sensor element of the sensor array wherein the fourth sensor element comprises a plurality of ligands of a ligand type that is an antibody for neuraminidase with a subtype selected from the group consisting of N2 through N9;

e. means for detecting multiple electrostatic output signals when an influenza virus containing a protein of a hemagglutinin subtype selected from the group consisting of H1 through H16 is introduced in proximity to the sensor elements and an influenza virus containing a protein of a neuraminidase subtype selected from the group consisting of N1 through N9 is introduced in proximity to the sensor elements;

f. means for controlling the sequencing of the selection of the sensor elements to read samples of the electrostatic output signals;

g. means for converting the electrostatic output signal samples to digital equivalent sample signals;

h. means for combining a plurality of digital equivalent sample signals from a same sensor element to form digital signature signals;

i. means for transmitting the digital signature signals to a digital signal processor which compares the digital signature signals to a library of pre-stored signature signals containing binding events representing a binding of an antibody for hemagglutinin with a hemagglutinin antigen with a subtype selected from the group consisting of H1 through H16 and a binding of an antibody for neuraminidase antigen with a subtype selected from the group consisting of N1 through N9; and

j. means for using the comparison to the library of pre-stored signature signals to identify the antigen that has been detected selected from the group consisting of hemagglutinin H1 through H16 and the antigen that has been detected selected from the group consisting of neuraminidase N1 through N9.

15. A system for determining the presence of a biological target in accordance with claim 1 further comprising:

a. a first sensor element of the sensor array wherein the first sensor element comprises a plurality of ligands of a p24 ligand type representing an antibody of a p24 antigen;

b. means for detecting a first electrostatic output signal when the p24 antigen is introduced in proximity to the first sensor element;

c. means for controlling the sequencing of the selection of the first sensor element to read samples of the first electrostatic output signal;

d. means for converting the first electrostatic output signals to a first digital equivalent sample signal;

e. means for combining a plurality of first digital equivalent sample signals from a same sensor element to form a first digital signature signal;

f. means for transmitting the first digital signature signal to a digital signal processor which compares the first digital signature signal to a library of pre-stored signature signals containing a first pre-stored signature signal representing a binding event when the p24 ligand type binds with the p24 antigen; and

g. means for generating an alert upon matching the first digital signature signal with the first pre-stored signature signal representing a p24 binding event.

28. A system for determining the presence of a biological target in accordance with claim 1 wherein the digital signature signal is a time domain signature signal which is compared to pre-stored signature time domain signals using cross-correlation techniques to determine a match.

29. A system for determining the presence of a biological target in accordance with claim 1 wherein the digital signature signal is converted to a frequency spectrum and then compared to pre-stored frequency spectrum signature signals using cross-correlation techniques to determine a match.

16. A system for determining the presence of a biological target, comprising:

a. at least one sensor element, each sensor element further comprising;

i. a plurality of ligands of at least one ligand type applied to a coating on the sensor element;

ii. an electrostatic output signal generated by the sensor element from an interaction when one of the plurality of ligands of the at least one ligand type binds to at least one biological target type;

iii. an electrostatic sensing surface, positioned in proximity to the at least one ligand for detecting the electrostatic output signal; and

iv. a measurement means for measuring the detected electrostatic output signal;

b. a controller to select and input samples of the electrostatic output signal of each sensor element;

c. means for converting the electrostatic output signal samples of the sensor element from an analog signal sample to a digital equivalent signal sample by a digital-to-analog converter, the digital equivalent signal sample being stored in the controller;

d. means for combining a plurality of digital equivalent signal samples from a same sensor element to form a digital signature signal;

e. means for transmitting the digital signature signal to a digital signal processor which compares each digital signature signal with a library of pre-stored signature signals representing known biological targets; and

f. means for generating a notification alert when the digital signature signal matches a pre-stored signal in the library of pre-stored signature signals that represents a signature generated when the at least one ligand type binds with the at least one biological target type.

17. A system for determining the presence of a biological target in accordance with claim 16 wherein:

a. the binding of the at least one ligand with the at least one biological target;

b. the detecting and measuring of the electrostatic output signal;

c. the controlling and the selecting of the electrostatic output signal of the sensor element;

d. the converting of the electrostatic output signal to the digital equivalent signal;

e. the transmitting and the comparing of the digital equivalent signal to the library of pre-stored signature signals representing known biological targets; and

f. said binding, detecting, measuring, controlling, converting, transmitting and comparing occurring in real-time.

18. A system for determining the presence of a biological target in accordance with claim 16 wherein the at least one ligand type is an antibody for a protein hemagglutinin subtype H5.

19. A system for determining the presence of a biological target in accordance with claim 16 wherein the at least one ligand type is an antibody for a protein neuraminidase subtype N1.

20. A system for determining the presence of a biological target in accordance with claim 16 wherein the at least one ligand type is an antibody for a protein P24.

21. A system for determining the presence of a biological target in accordance with claim 16 further comprising at least one ligand type selected from the group consisting of an antibody for the proteins hemagglutinin and neuraminidase.

22. A system for determining the presence of a biological target in accordance with claim 16 further comprising at least one ligand type selected from the group consisting of an antibody for the protein P24.

23. A system for determining the presence of a biological target in accordance with claim 18 wherein the at least one biological target type are antigens of the protein hemagglutinin subtype H5 that bind with the at least one ligand type antibody for the protein hemagglutinin subtype H5.

24. A system for determining the presence of a biological target in accordance with claim 19 wherein the at least one biological target type are antigens of the protein neuraminidase subtype N1 that bind with the at least one ligand type antibody for the protein neuraminidase subtype N1.

25. A system for determining the presence of a biological target in accordance with claim 20 wherein the at least one biological target type are antigens of the protein p24 that bind with the at least one ligand type antibody for the protein p24.

26. A system for determining the presence of a biological target in accordance with claim 16 further comprising:

a. a first sensor element comprising a plurality of ligands of a first ligand type that is an antibody for hemagglutinin subtype H5;

b. a second sensor element comprising a plurality of ligands of a second ligand type neuraminidase subtype N1;

c. means for detecting a first electrostatic output signal when an influenza virus containing an hemagglutinin subtype H5 antigen is introduced in proximity to the first sensor element;

d. means for detecting a second electrostatic output signal when an influenza virus containing an neuraminidase subtype N1 antigen is introduced in proximity to the second sensor element;

e. means for controlling the sequencing of the selection of the first and second sensor elements to read samples of the first and second electrostatic output signals;

f. means for converting the first and second electrostatic output signal samples to first and second digital equivalent signal samples;

g. means for combining a plurality of first digital equivalent signal samples from a same sensor element to form a first digital signature signal and means for combining a plurality of second digital equivalent signal samples from a same sensor element to form a second digital signature signal;

h. means for transmitting the first and second digital signature signals to a digital signal processor which compares the first and second digital signature signals to the library of pre-stored signature signals containing a first pre-stored signature signal representing a binding event when the first ligand type for hemagglutinin subtype H5 binds with a hemagglutinin subtype H5 antigen and a second pre-stored signature signal representing a binding event when the second ligand type for neuraminidase subtype N1 binds with a neuraminidase subtype N1 antigen; and

i. means for generating an alert upon matching both the first signature signal with the first pre-stored signature signal and the second signature signal with the second pre-stored signature signal.

27. A system for determining the presence of a biological target in accordance with claim 16 further comprising:

a. a first sensor element comprising a plurality of ligands of a first ligand type that is an antibody for hemagglutinin subtype H5;

b. a second sensor element comprising a plurality of ligands of a second ligand type that is an antibody for neuraminidase subtype N1;

c. means for detecting a first electrostatic output signal when an influenza virus containing an hemagglutinin subtype antigen selected from the group consisting of H1 through H4 and H6 through H16 is introduced in proximity to the first and second sensor elements;

d. means for detecting a second electrostatic output signal when an influenza virus containing a neuraminidase subtype antigen selected from the group consisting of N2 through N9 is introduced in proximity to the first and second sensor elements;

e. means for controlling the sequencing of the selection of the first and second sensor elements to read samples of the first and second electrostatic output signals;

f. means for converting the first and second electrostatic output signal samples to first and second digital equivalent signal samples;

g. means for combining a plurality of first digital equivalent signal samples to form a first digital signature signal and means for combining a plurality of second digital equivalent signal samples to form a second digital signature signal;

h. means for transmitting the first and second digital signature signals to a digital signal processor which compares the first and second digital signature signals to a library of pre-stored signature signals containing binding events representing a binding of an antibody for hemagglutinin subtype selected from the group consisting of H1 through H16 and a binding of an antibody for neuraminidase subtype selected from the group consisting of N1 through N9; and

i. means for indicating that the antigen hemagglutinin subtype selected from the group consisting of H1 through H4 and H6 through H16 and the antigen neuraminidase subtype selected from the group consisting of N2 through N9 have been detected.

30. A system for determining the presence of a biological target in accordance with claim 16 wherein the digital signature signal is a time domain signature signal which is compared to pre-stored signature time domain signals using cross-correlation techniques to determine a match.

31. A system for determining the presence of a biological target in accordance with claim 16 wherein the digital signature signal is converted to a frequency spectrum and then compared to pre-stored frequency spectrum signature signals using cross-correlation techniques to determine a match.